Genetic analysis: Detection of mutations in gene of alpha-synuclein (SNCA)
DNA Isolation: under aseptic conditions, from each one of the patients, blood sample was taken, with the function of a vein. Each of those blood samples are kept invaccum pots (Vaccutainer), and anticoagulant EDTA Na2 is added in each of the pots. Amplification: amplification of regions of SNCA gene was made with polymerase chain reaction. Detection of mutations: to detect the mutations in selected regions of SNCA gene, polymerase chain reaction-Restriction Fragment Length Polymorphism, was used. Amplification of the region of egzon 3 of SNCA gene was made, using the primers 5'-GTC TCA CAC TTT GGA GGG TTT C-3' and 5' CAC CTA CCT ACA CAT ACC TCT GAC and TC-3'. PCR amplification of region of egzon 4 of SNCA gene was made by using the primers 5' GCT AAT CAG CAA TTT AAG GCT AG-3' and 5' GAT ATG TTC TTA GAT GCT and CAG-3'. All of these amplifications have length of 215 bp. Amplificated products were digested with appropriate restrictive endonuclease under the optimal conditions. G88C mutation in egzon 3 of SNCA gene was detected with restricted digestion with enzyme Mval. G209A mutation in egzon 4 of SNCA gene was detected with enzyme Mael.
Results
In this part of the article, we have a presentation of the results gained with processing, in other words, a statistic data analysis, needed for fulfilling the research aims set. As respondents in the research, we've included 32 patients with clinically confirmed Idiopathic Parkinson's disease (IPD), diagnosed to Brain Bank Criteria, treated in the University Clinic of Neurology in Skopje -ward for extra pyramidal diseases. The gender structure of the respondents is presented with 18 (56.25%) males and 14 (43.75%) females, table 1 and picture 1. The average age of the respondents is 52, 7+10.3 years. The youngest respondent is 30 years and the oldest is 78 years. The median value with value of 50 years shows that 16 of the respondents (50%) are in the age group of 50-59 years, and even 23 of the patients are older than 50 years, 
Mutation detection
After amplification of a region from egzon 3 of SNCA gene, with usage of the following primers: 5'GTC TCA CAC TTT GGA GGG TTT C-3 and 5'-CAC CTA CCT ACA CAT ACC TCT GAC TC-3', the result was an amplified product with length of 395 base pairs (bp). PCR amplification of a region from egzon 4 of SNCA gene, was performed with these primers 5'-GTC AAT CAG CAA TTT AAG GCT AG-3' and 5'-GAT ATG TTC TTA GAT GCT CAG-3', and the amplifications have length of 215 bp. The amplified products were digested with proper restrictive endonuclease under optimal conditions (puferian solutions suitable for each enzyme separately on temperature of 37 c). With that, no mutated sequence in the PCR product is found. G88C mutation in egzon 3 of SNCA gene isn't detected in our 32 respondents with IPD. No mutations were found in the G209A in the enzon 4 from SNCA gene, also. [1] . Bradykinesia or the of stuntment in movements, as main from the list of cardinal symptoms according to Brain Bank Criteria of UK Parkinson's Disease (BBC-UKPCD), was present in all respondents. According to BBC-UKPCD criteria, to set the JPD diagnosis, the patient should have bradykinesia plus one of the rest cardinal symptoms such as tremor, rigidity or reduced postural reflexes. With the presence of only 2 symptoms (from which one must be bradykinesia) IPD can be confirmed. Bradykinesia as cardinal symptom according to UPRDS, was estimated in the following way: 15 patients (47.87%) with 1; 10 (31.25%) with 2; 5 (15.62%) with 3 and only 2 respondents (6.25%) with 4 according to UPRDS scale. Stefanie Lui and all. (2009) in their study make analysis of the development of bradykinesia as symptom in different disease stadiums. According to them, the disease progression is influenced from the bradykinesia as main cardinal symptom [19] . When our respondents are in question, in only one of them (3.12%), the lack of symptom reduced postural reflexes was confirmed and its value was 0, according to UPDRS scale. In our respondents, 75% had reduced postural reflexes, estimated with 1; 5 (15.62 %) with 2 and 1 (3.12%) were with values of 3 and 4. Spildoren I and all. (2010), in their article described the postural instability as common and very important symptoms in IPD. In their patients, this instability is seen through partial walking instability in the initial disease stadium and as freezing phenomena in the advanced disease stadiums. According to them, the freezing phenomena are often expressed in simultaneous double activities and in the act of turning after short walking [13] . Kerstin Ziegler and all. (2010), describe festination and freezing in all 33 patients with more advanced stadium of IPD. The way they estimated festination and freezing in walking, was with 12 episodes walking capturing, in which motor block was seemed in 4 situations with 3 levels of double activities. Practically, these phenomenas are reflected in parameters expressed by measuring the number of steps of those patients, walking on special stripe and analysis on walking on distance of 10 meters. This is how you make assessment on expression of the postural instability [14] . Besides bradykinesia, as main cardinal symptom, as symptoms od IPD, are also found tremor and rigidity. We've found their presence in all our respondents (100%).
Tremor is estimated with 2, according to UPDRS scale in 18 respondents (56.25%); 10 (31.25%) with 1; 3 (9.4%) with 3 and only one patient (3.1%) we've found tremor estimated with 4. Petra Vingensuh and all (2010) conducted examination on 25 respondents in initial stadium of IPD. In all of them, unilateral tremor pointed with bradykinesia was found, and it was possible to make diagnosis. Additionally, all these patients gained SPECT testing and in only 10% a proper finding of SPEKT was found. Lately, a number of articles are published, which through examination of cardinal secondary symptoms in patients with IPD, make analysis on their life quality. In our article, the estimation of the immensity of the clinical state was made using the UPDRS scale, which is generally accepted and applied in most scientific articles for Parkinson's disease [6] . The correlation between respondents' age and the immensity of the clinical state, estimated according to UPDRS scale, is shown in picture 26 in our results. This relation points the existence or negative correlation. Parkinson's disease has fairly difficult clinical state in younger patients and vice verse; the disease is manifested with lighter symptoms in elder patients. But, considering the coefficient value, we can conclude the correlation between these two parameters is statistically insignificant (p>0.05). Barone P and all. (2009), this multicentrical article shows the frequency of the nonmotor signs and symptoms such as hyposmia, mood, sleeping, tiredness, perception difficulties, attention, memory capacity, erectil disfunction [3] . All these signs are examined in patients on different disease stadiums, and than analyzed to present their influence on the life of these patients. The authors monitor 524 patients with Parkinson's disease, and they register their nonmotor symptoms and their influence on patients' life in different disease stadiums. They stated, that in younger patients the clinical state is tougher according to UPDRS, comparing to elder patients. Also, the study witnessed that disease progression is much faster in younger patients comparing to elder patients [3] . Keush SH and all. (2009), conducted their clinical examination of motor and nonmotor symptoms of Parkinson's disease in Holland. The authors developed a specific scale through which, the possibilities and capabilities for daily activities were analyzed, and according to which the degree of disease progression can be determined. According to them, in younger patients we have faster symptoms progression, comparing to patients where the clinical state is manifested later [15] . They also had plenty symptoms and the exact regions which influenced the domination on specific motor and nonmotor symptoms, were determinated. Dementia as a symptom was excluded [4] . Table 11a and 11b from our results, presents the results from the neuropsychological testing.
Proper cognitive capacities of testing were found only in 3 patients with IPD. Between the patients dominant are those with depression and initial reduced cognitive capacities (34.4%), as well as 31.2% with global reduced cognitive capacities. According to the frequency of occurrence, next is the finding of depression and global reduced cognitive capacities, found in 9.4% of our respondents. The rest findings of the neuropsychological testing: depression in behavior, anxiety in behavior, initial reduced cognitive capacities; depression and anxiety in behavior, as well as the mutual presence of depression and anxiety in behavior and initial reduced cognitive capacities are found only in 1 patient with IPD. Lately, in different magazines and congresses, scientists try to prove the correlation between the IPD and depression as secondary symptom, as well as, dementia, found in high percent of patients with Parkinson's disease. Ivi N Miler and Golumb AC (2010) made interesting clinical and epidemiological study, where they proved that the disease is nearly equally manifested in both genders. But, certain symptoms more often appear in females and other in males. Etiopathogenetical mechanisms for these symptoms division, is still unknown, but it is assumed that the hormonal status influences on manifestation of these symptoms. Consequently, the nonvoter symptoms (mood, hyposmia, sleeping, attention, memory, perception difficulties and depression) are dominant in females [11] . Huijuan Li and all. (2010), made a study on 82 Chinese patients, 46 males and 36 females with IPD, which lasted 18 months. Patients were on average age of 65 years. Generally, they examined the motor signs such as: mood, sleeping, depression, attention, memory capacity and perception disorder. To determinate the degree of disease, the authors used UPDRS scale. Then using a special scale for determination of nonmotoral symptoms development, they determined the degree of these symptoms. They concluded that there is a positive correlation between the development of the nonmotor and psychological symptoms in relation to the development of motor signs of the disease, according to UPDRS. Actually, all
